Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Cancer Res. 2020 Jul 24;26(21):5701–5708. doi: 10.1158/1078-0432.CCR-20-1825

Table 1:

Clinical characteristics of patients with advanced NSCLC by SMARCA4 alteration class.

Characteristic SMARCA4
Class 1
(N = 149)
SMARCA4
Class 2
(N = 143)
SMARCA4
Wild type
(N = 996)
P-value
Median Age (Q1, Q3) 65 (58, 72) 65 (59, 72) 65 (58, 73) 0.7
Sex 0.052
 Female 74 (50%) 78 (55%) 593 (60%)
 Male 75 (50%) 65 (45%) 403 (40%)
Race 0.13
 White 124 (83%) 125 (87%) 775 (78%)
 Black 7 (5%) 7 (5%) 57 (6%)
 Asian 10 (7%) 6 (4%) 101 (10%)
 Other 8 (5%) 5 (4%) 63 (6%)
Smoking <0.001
 Never smoker 17 (11%) 26 (18%) 315 (32%)
 Former light (<15 py) 20 (13%) 19 (13%) 165 (17%)
 Former heavy (>15 py) 80 (54%) 71 (50%) 373 (37%)
 Current smoker 32 (21%) 27 (19%) 131 (13%)
Histology <0.001
 Adenocarcinoma 121 (81%) 125 (87%) 914 (92%)
 Other 28 (19%) 18 (13%) 82 (8%)

py: pack years